Risk of developing Alzheimer’s disease and related dementias in association with cardiovascular disease, stroke, hypertension, and diabetes in a large cohort of women with breast cancer and with up to 26 years of follow-up

Manuscript Number: 

21-5657R1

Author(s): 
Wenyaw Chan, Xianglin L. Du, Paul E. Schulz, Lulu Song, Hua Xu

Disclosures

Wenyaw Chan

  • Nothing to Disclose

Xianglin L. Du

  • Nothing to Disclose

Paul E. Schulz

  • Consulting Fees:
    Occasional Biogen, Lilly, and Acadia advisory board member. None regularly. None related to this paper, in my opinion.
    Lecture Fees:
    Occasional disease state education talks for Biogen and Acadia. None are product specific or related to this manuscript.

Lulu Song

  • Nothing to Disclose

Hua Xu

  • Consulting Fees:
    Dr. Xu served as an advisor at the oncology real world data advisory board at Bayer Dr. Xu served as a consultant at Melax Technologies Inc.
    Equity:
    Dr. Xu owns equity at Melax Technologies Inc.